HLA-B47
major histocompatibility complex (human), class I, B47
| ||
| Alleles | B*4701 B*4702 B*4703 | |
| Structure (See HLA-B) | ||
| Symbol(s) | HLA-B | |
| EBI-HLA | B*4701 | |
| EBI-HLA | B*4702 | |
| EBI-HLA | B*4703 | |
| Locus | chr.6 6p21.31 | |
|
WikiDoc Resources for HLA-B47 |
|
Articles |
|---|
|
Most recent articles on HLA-B47 |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on HLA-B47 at Clinical Trials.gov Clinical Trials on HLA-B47 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on HLA-B47
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating HLA-B47 Risk calculators and risk factors for HLA-B47
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for HLA-B47 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
HLA-B47 (B47) is an HLA-B serotype. The serotype identifies the HLA-B*47 gene products (B*4701, B*4702, B*4703) .[1] Comparison of B47 nucleotide sequence with other HLA-B sequences shows a segment of 228 bp identical with B44 in the alpha 1 domain and a segment of 218 bp identical with B27 in the alpha 2 domain, but only a 91 bp segment of identity with B13 in the alpha 1 domain. The complex pattern of substitutions and their degree of divergence indicate that HLA-B13 and HLA-Bw47 alleles are not related by a simple mutational event.[2] B47 is linked to (close to on the chromosome) a gene that causes adrenal deficiency. B47 is generally low in frequency and with highest known frequencies in Central and Western Africa. (For terminology help see: HLA-serotype tutorial)
Serotype
| B*47 | B47 | Other | Sample |
| allele | % | % | size (N) |
| 4701 | 50 | 37 | 317 |
| 4702 | 40 | 40 | 5 |
| 4703 | 25 | 50 | 4 |
Serotyping for B47 is poor and typing is best performed with SSP-PCR or gene sequencing.
Disease Associations
B47 is linked to Adrenal 21-hydroxylase deficiency.[2] The CYP21 gene is located close to B47 between HLA-B and HLA-DRB1 locus.
B*4701 frequencies
| freq | ||
| ref. | Population | (%) |
| [4] | Bamileke (Cameroon) | 2.6 |
| [4] | Zapotec (Oaxaca, Mexico) | 2.2 |
| [4] | Niokholo Mandinka (Senegal) | 1.6 |
| [4] | Mbenzele Pygmy (CAR) | 1.5 |
| [4] | Nandi (Kenya) | 1.3 |
| [4] | Sudanese | 1.3 |
| [4] | Yaounde City (Cameroon) | 1.1 |
| [4] | Lusaka (Zambia) | 1.1 |
| [4] | Central Portugal | 1.0 |
| [4] | Bulgaria | 0.9 |
| [4] | Czech Republic | 0.9 |
| [4] | Cape Verde Islands | 0.8 |
| [4] | Berber (Morocco) | 0.7 |
| [4] | Finland | 0.6 |
| [4] | Svans (Georgia) | 0.6 |
| [4] | Bergamo (Italy) | 0.6 |
| [4] | Romanians | 0.6 |
| [4] | North Delhi ((India)) | 0.5 |
| [4] | Orkney Isles (Scotland) | 0.5 |
| [4] | Basque (Guipuscoa, Spain) | 0.5 |
| [4] | Southeastern (France) | 0.4 |
| [4] | Oman | 0.4 |
| [4] | Kenya | 0.3 |
Orange = 1 to 3%
Yellow = 0.1 to 1%
References
- ↑ Marsh SG, Albert ED, Bodmer WF; et al. (2005). "Nomenclature for factors of the HLA system, 2004". Tissue Antigens. 65 (4): 301–69. doi:10.1111/j.1399-0039.2005.00379.x. PMID 15787720.
- ↑ Jump up to: 2.0 2.1 Zemmour J, Ennis PD, Parham P, Dupont B (1988). "Comparison of the structure of HLA-B47 to HLA-B13 and its relationship to 21-hydroxylase deficiency". Immunogenetics. 27 (4): 281–7. PMID 3257938.
- ↑ derived from IMGT/HLA
- ↑ Jump up to: 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 Middleton D, Menchaca L, Rood H, Komerofsky R (2003). "New allele frequency database: http://www.allelefrequencies.net". Tissue Antigens. 61 (5): 403–7. PMID 12753660. External link in
|title=(help)